Clinical Observation of SGLT2 Inhibitor Therapy for Cardiac Arrhythmia and Related Cardiovascular Disease in Diabetic Patients with Controlled Hypertension

Clinical Observation of SGLT2 Inhibitor Therapy for Cardiac Arrhythmia and Related Cardiovascular Disease in Diabetic Patients with Controlled Hypertension

Sodium-glucose transporter 2 (SGLT2) inhibitors are new glucose-lowering agents that have been proven to be beneficial for patients with cardiovascular diseases, heart failure, and sudden cardiac death. However, the possible protective effects of cardiac arrhythmia have not yet been clarified in cli...

Full description

Bibliographic Details
Main Authors: Shih-Jie Jhuo, Tsung-Hsien Lin, Yi-Hsiung Lin, Wei-Chung Tsai, I-Hsin Liu, Bin-Nan Wu, Kun-Tai Lee, Wen-Ter Lai
Format: Article
Language:English
Published: MDPI AG 2022-02-01
Series:Journal of Personalized Medicine
Subjects:
SGLT2 inhibitor
diabetes
atrial fibrillation
cardiac arrhythmia
Online Access:https://www.mdpi.com/2075-4426/12/2/271

Internet

https://www.mdpi.com/2075-4426/12/2/271

Similar Items